XTLB - XTL Biopharmaceuticals Ltd.
- XTL Biopharma plunges on Bicifadine trial failure
Nov 18, 11:23 AM EST - (AP) - XTL Biopharma downgraded by Ladenburg Thalmann
Nov 18, 9:45 AM EST - (Briefing.com) - UPDATE - XTL's diabetic pain drug fails in trial, shares sink
Nov 18, 8:50 AM EST - (at Reuters) - XTL Biopharmaceuticals Announces Top-Line Results From the Bicifadine Phase 2b Study for Diabetic Neuropathic Pain
Nov 18, 8:05 AM EST - (PR Newswire) - Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
Oct 10, 2:00 PM EDT - (PR Newswire) - XTL Biopharmaceuticals Announces Completion of the Bicifadine Phase 2b Study for Diabetic Neuropathic Pain
Oct 7, 7:35 AM EDT - (PR Newswire) - XTL Biopharmaceuticals Extraordinary General Meetings Postponed Until October 10, 2008
Oct 2, 11:37 AM EDT - (PR Newswire) - Get Ready for the Fall
Sep 2, 1:21 PM EDT - (at Motley Fool) - XTL BIOPHARMACEUTICALS LTD Financials
Apr 11, 9:04 AM EDT - (EDGAR Online Financials)
Open a Brokerage Account and Start Trading Today!
100% Free Stock Trade. Trade stocks for free on Zecco.com. The Free Trading Community. www.zecco.com
100% Free Stock Trade. Trade stocks for free on Zecco.com. The Free Trading Community. www.zecco.com